arrow_back Back to App

Stem Cell and Cord Blood Programs Reauthorized and Funded Through 2031

This act extends funding and operations for programs supporting stem cell transplants and cord blood banks. This means individuals needing these therapies will continue to have access, and research and development in this field will proceed, potentially improving the quality of life for many patients.
Key points
The C.W. Bill Young Cell Transplantation Program will receive an additional $33,009,000 annually for fiscal years 2027-2031.
The national cord blood inventory, crucial for patients seeking donors, has been extended until 2031.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_5160
Sponsor: Rep. Smith, Christopher H. [R-NJ-4]
Process start date: 2025-09-04
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Stem Cell Therapeutic and Research Reauthorization Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_5160.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-04.

What are the main provisions?

Key points include:

  • The C.W. Bill Young Cell Transplantation Program will receive an additional $33,009,000 annually for fiscal years 2027-2031.
  • The national cord blood inventory, crucial for patients seeking donors, has been extended until 2031.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Smith, Christopher H. [R-NJ-4].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health